On March 11, 2022, Douglas A. Roeder, notified Tandem Diabetes Care, Inc. of his decision not to stand for re-election at the Company's 2022 Annual Meeting of Stockholders (the 2022 Annual Meeting). Mr. Roeder has served on the Board since May 2009 and is currently serving as a Class III director with a term that will end concurrent with the 2022 Annual Meeting. The decision by Mr. Roeder not to stand for re-election did not involve a disagreement with the Company on any matter relating to the Company's operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.35 USD | -2.15% | -9.01% | +60.07% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+60.07% | 3.06B | |
-5.17% | 182B | |
-0.18% | 108B | |
-4.04% | 67.62B | |
-5.55% | 46.61B | |
+12.06% | 45.32B | |
+6.47% | 42.11B | |
+20.33% | 31.17B | |
+13.26% | 25.66B | |
-3.89% | 24.65B |
- Stock Market
- Equities
- TNDM Stock
- News Tandem Diabetes Care, Inc.
- Tandem Diabetes Care, Inc. Announces That Douglas A. Roeder Notified His Decision Not to Stand for Re-Election